Pathologic Stage IIB Gastric Cancer AJCC v8
7 clinical trials · Condition
◉ Watch Pathologic Stage IIB Gastric Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172) | Thomas Jefferson University | 2020-11-10 |
| Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma (NCT04523818) | M.D. Anderson Cancer Center | 2020-08-11 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
| Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery (NCT03997162) | City of Hope Medical Center | 2018-10-11 |
Track Pathologic Stage IIB Gastric Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.